Genipin protects lipopolysaccharide-induced apoptotic liver damage in d-galactosamine-sensitized mice

European Journal of Pharmacology

Volumn 635, Issue 1-3, 2010, Pages 188-193

  Kim, Seok Joo ^a   Kim, Joon Ki ^a   Lee, Dong Ung ^b   Kwak, Jong Hwan ^a   Lee, Sun Mee ^a  

^a Sungkyunkwan University   (South Korea)

^b Dongguk University   (South Korea)

Author keywords

Apoptosis; Fulminant hepatic failure; Galactosamine lipopolysaccharide; Genipin

Indexed keywords

AMINOTRANSFERASE; CASPASE 3; CASPASE 8; CYTOCHROME C; GALACTOSAMINE; GENIPIN; GLUTATHIONE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PROTEIN C JUN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RESPONSE; ENZYME BLOOD LEVEL; LIPID PEROXIDATION; LIVER FAILURE; LIVER PROTECTION; MALE; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SURVIVAL RATE;

ANIMALS; APOPTOSIS; CASPASES; CELL NUCLEUS; CYTOCHROMES C; CYTOSOL; GALACTOSAMINE; GENE EXPRESSION REGULATION; GLUTATHIONE; I-KAPPA B PROTEINS; IRIDOIDS; LIPID PEROXIDATION; LIPOPOLYSACCHARIDES; LIVER; LIVER FAILURE, ACUTE; MALE; MICE; MICE, INBRED ICR; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-JUN; TNF RECEPTOR-ASSOCIATED DEATH DOMAIN PROTEIN; TRANSAMINASES; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77952322170     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.03.007     Document Type: Article

References (30)

1. Adler V., Polotskaya A., Wagner F., Kraft A.S. Affinity-purified c-Jun amino-terminal protein kinase requires serine/threonine phosphorylation for activity. J. Biol. Chem. 1992, 267:17001-17005.
2. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science 1998, 281:1305-1308.
3. Becker C., Barbulescu K., Wirtz S., Meyer zum Buschenfelde K.H., Pettersson S., Neurath M.F. Constitutive and inducible in vivo protein-DNA interactions at the tumor necrosis factor-alpha promoter in primary human T lymphocytes. Gene Expr. 1999, 8:115-127.
4. Brouckaert P., Fiers W. Tumor necrosis factor and the systemic inflammatory response syndrome. Curr. Top. Microbiol. Immunol. 1996, 216:167-187.
5. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Meth. Enzymol. 1978, 52:302-310.
6. Chen Y.S., Chang J.Y., Cheng C.Y., Tsai F.J., Yao C.H., Liu B.S. An in vivo evaluation of a biodegradable genipin-cross-linked gelatin peripheral nerve guide conduit material. Biomaterials 2005, 26:3911-3918.
7. Galanos C., Freudenberg M.A., Reutter W. Galactosamine induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. USA 1979, 76:5939-5943.
8. Ghosh S., May M.J., Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 1998, 16:225-260.
9. Han D., Hanawa N., Saberi B., Kaplowitz N. Hydrogen peroxide and redox modulation sensitize primary mouse hepatocytes to TNF-induced apoptosis. Free Radic. Biol. Med. 2006, 41:627-639.
10. Hong J.Y., Lebofsky M., Farhood A., Jaeschke H. Oxidant stress-induced liver injury in vivo: role of apoptosis, oncotic necrosis, and c-Jun NH2-terminal kinase activation. Am. J. Physiol. 2009, 296:G572-G581.
11. Ip Y.T., Davis R.J. Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr. Opin. Cell Biol. 1998, 10:205-219.
12. Jensen S.R. Iridoids in Rothmannia globosa. Phytochem. 1983, 22:1761-1765.
13. Kaufmann T., Jost P.J., Pellegrini M., Puthalakath H., Gugasyan R., Gerondakis S., Cretney E., Smyth M.J., Silke J., Hakem R., Bouillet P., Mak T.W., Dixit V.M., Strasser A. Fatal hepatitis mediated by tumor necrosis factor TNFalpha requires caspase-8 and involves the BH3-only proteins Bid and Bim. Immunity 2009, 30:56-66.
14. Kawaguchi K., Kikuchi S., Hasegawa H., Maruyama H., Morita H., Kumazawa Y. Suppression of lipopolysaccharide-induced tumor necrosis factor-release and liver injury in mice by naringin. Eur. J. Pharmacol. 1999, 368:245-250.
15. Kim S.H., Kim Y.S., Kang S.S., Bae K., Hung T.M., Lee S.M. Anti-apoptotic and hepatoprotective effects of gomisin A on fulminant hepatic failure induced by d-galactosamine and lipopolysaccharide in mice. J. Pharmacol. Sci. 2008, 106:225-233.
16. Koo H.J., Song Y.S., Kim H.J., Lee Y.H., Hong S.M., Kim S.J., Kim B.C., Jin C., Lim C.J., Park E.H. Antiinflammatory effects of genipin, an active principle of gardenia. Eur. J. Pharmacol. 2004, 495:201-208.
17. Lee S.J., Oh P.S., Lim K.T. Hepatoprotective and hypolipidaemic effects of glycoprotein isolated from Gardenia jasminoides Ellis in mice. Clin. Exp. Pharmacol. Physiol. 2006, 33:925-933.
18. Lin B.R., Yu C.J., Chen W.C., Lee H.S., Chang H.M., Lee Y.C., Chien C.T., Chen C.F. Green tea extract supplement reduces d-galactosamine-induced acute liver injury by inhibition of apoptotic and proinflammatory signaling. J. Biomed. Sci. 2009, 16:35.
19. Liu L.M., Zhang J.X., Luo J., Guo H.X., Deng H., Chen J.Y., Sun S.L. A role of cell apoptosis in lipopolysaccharide (LPS)-induced nonlethal liver injury in d-galactosamine (d-GalN)-sensitized rats. Dig. Dis. Sci. 2008, 53:1316-1324.
20. Lu J.W., Wang H., Yan-Li J., Zhang C., Ning H., Li X.Y., Zhang H., Duan Z.H., Zhao L., Wei W., Xu D.X. Differential effects of pyrrolidine dithiocarbamate on TNF-alpha-mediated liver injury in two different models of fulminant hepatitis. J. Hepatol. 2008, 48:442-452.
21. Morin D., Pires F., Plin C., Tillement J.P. Role of the permeability transition pore in cytochrome C release from mitochondria during ischemia-reperfusion in rat liver. Biochem. Pharmacol. 2004, 68:2065-2073.
22. Osawa Y., Nagaki M., Banno Y., Yamada Y., Imose M., Nozawa Y., Moriwaki H., Nakashima S. Possible involvement of reactive oxygen species in d-galactosamine-induced sensitization against tumor necrosis factor-alpha-induced hepatocyte apoptosis. J. Cell Physiol. 2001, 187:374-385.
23. Shakil A.O., Kramer D., Mazariegos G.V., Fung J.J., Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl. 2000, 6:163-169.
24. Shang Y., Liu Y., Du L., Wang Y., Cheng X., Xiao W., Wang X., Jin H., Yang X., Liu S., Chen Q. Targeted expression of uncoupling protein 2 to mouse liver increases the susceptibility to lipopolysaccharide/galactosamine-induced acute liver injury. Hepatology 2009, 50:1204-1216.
25. Takai S., Nagaki M., Imao M., Kimura K., Kozawa O., Moriwaki H. Intrinsic resistance to TNF-alpha-induced hepatocyte apoptosis in ICR mice correlates with expression of a short form of c-FLIP. Lab. Invest. 2007, 87:572-581.
26. Takamura M., Matsuda Y., Yamagiwa S., Tamura Y., Honda Y., Suzuki K., Ichida T., Aoyagi Y. An inhibitor of c-Jun NH2-terminal kinase, SP600125, protects mice from d-galactosamine/lipopolysaccharide-induced hepatic failure by modulating BH3-only proteins. Life Sci. 2007, 80:1335-1344.
27. Takeuchi S., Goto T., Mikami K., Miura K., Ohshima S., Yoneyama K., Sato M., Shibuya T., Watanabe D., Kataoka E., Segawa D., Endo A., Sato W., Yoshino R., Watanabe S. Genipin prevents fulminant hepatic failure resulting in reduction of lethality through the suppression of TNF-alpha production. Hepatol. Res. 2005, 33:298-305.
28. Xu Y., Bialik S., Jones B.E., Iimuro Y., Kitsis R.N., Srinivasan A., Brenner D.A., Czaja M.J. NF-kappaB inactivation converts a hepatocyte cell line TNF-alpha response from proliferation to apoptosis. Am. J. Physiol. 1998, 275:C1058-C1066.
29. Xu M., Sun Q., Su J., Wang J., Xu C., Zhang T., Sun Q. Microbial transformation of geniposide in Gardenia jasminoides Ellis into genipin by Penicillium nigricans. Enzyme Microb. Technol. 2008, 42:440-444.
30. Yamamoto M., Miura N., Ohtake N., Amagaya S., Ishige A., Sasaki H., Komatsu Y., Fukuda K., Ito T., Terasawa K. Genipin, a metabolite derived from the herbal medicine Inchin-ko-to, and suppression of Fas-induced lethal liver apoptosis in mice. Gastroenterology 2000, 118:380-389.